Horizon Pharma Sees Mid-2019 BLA For Tepro After Solid Phase III TED Data

 
• By Sten Stovall
  
Eye
OPTIC Phase III Study Was In thyroid eye disease (TED) • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Sensory

More from Therapeutic Category